Overview
I am an Adult and Pediatric Rheumatologist and care for patients with a wide variety of autoimmune and rheumatic diseases, including: systemic lupus, rheumatoid arthritis, juvenile arthritis, vasculitis, and sarcoidosis, among others. I have a special interest in using musculoskeletal ultrasound to optimize diagnosis and treatment decisions at the bedside.
I am also a clinical researcher at the Duke Clinical Research Institute (DCRI). My research interests are in clinical trials and precision medicine through population pharmacokinetic/pharmacodynamic modeling. I obtained my PhD in Pharmaceutical Sciences from the UNC Eshelman School of Pharmacy. I serve as the principal investigator on several grants studying hydroxychloroquine and azathioprine pharmacokinetics and exposure-response in lupus, as well as principal investigator or co-investigator for several clinical trials at the DCRI. Additionally, I am an Assistant Scientific Director for the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry- the largest registry of children with rheumatic diseases in North America.
I am also a clinical researcher at the Duke Clinical Research Institute (DCRI). My research interests are in clinical trials and precision medicine through population pharmacokinetic/pharmacodynamic modeling. I obtained my PhD in Pharmaceutical Sciences from the UNC Eshelman School of Pharmacy. I serve as the principal investigator on several grants studying hydroxychloroquine and azathioprine pharmacokinetics and exposure-response in lupus, as well as principal investigator or co-investigator for several clinical trials at the DCRI. Additionally, I am an Assistant Scientific Director for the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry- the largest registry of children with rheumatic diseases in North America.
Current Duke Appointments & Affiliations
Associate Professor of Pediatrics
·
2022 - Present
Pediatrics, Rheumatology,
Pediatrics
Associate Professor of Medicine
·
2022 - Present
Medicine, Rheumatology and Immunology,
Medicine
Member in the Duke Clinical Research Institute
·
2018 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Scholarly Works
Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All.
Journal article Arthritis Rheumatol · June 2026 Full text Link to item CitePopulation Pharmacokinetics and Dosing Simulations of Pentobarbital in the Pediatric Population.
Journal article J Clin Pharmacol · May 2026 Pentobarbital is a barbiturate with sedative and anticonvulsant properties, occasionally used in pediatric patients for preoperative sedation, deep sedation during mechanical ventilation, and seizure control. Despite its long-standing clinical use, age-app ... Full text Link to item CiteCumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study.
Journal article Arthritis Care Res (Hoboken) · April 3, 2026 OBJECTIVE: Social determinants of health (SDOH) contribute to juvenile idiopathic arthritis (JIA) disparities, but most studies have assessed SDOH independently rather than cumulatively across individual, family, and neighborhood levels. Using a socioecolo ... Full text Link to item CiteRecent Grants
INNOVATE (Integrated National Network for Obstetric and Pediatric AdVAncement in Therapeutic Education)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2026 - 2031Azathioprine Safety and Pharmacokinetics in Pregnant Women with Rheumatic Disease and their Infants
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2026 - 2031PTN 3.0 Task Order #2_ BPCA Pediatric Drug Development Clinical Trial Infrastructure
ResearchProject Leader · Awarded by National Institutes of Health · 2025 - 2030View All Grants
Education
University of North Carolina, Chapel Hill ·
2022
Ph.D.
Duke University, School of Medicine ·
2018
M.H.S.
Marshall University ·
2010
M.D.